VEGFA and neoplasm: Preclinical data demonstrated that vascular endothelial growth factor (VEGF) was continuously expressed during oncogenesis, tumor growth and metastasis, by facilitating tumor angiogenesis, and prolonged exposure to VEGF inhibitors could delay tumor growth and even maintain tumor regression21–23.